Renal dysfunction in patients with chronic liver disease

Area of Science:

• Hepatology
• Nephrology
• Cardiovascular Physiology

Background:

• Chronic liver disease, particularly cirrhosis, is associated with a spectrum of renal dysfunction.
• Hyperdynamic circulation, characterized by peripheral arterial vasodilatation, is increasingly recognized as a key factor in renal impairment in these patients.
• Nitric oxide is implicated as a central mediator in the progressive vasodilatation observed in cirrhosis.

Purpose of the Study:

• To elucidate the pathophysiology of renal dysfunction in chronic liver disease.
• To highlight the role of hyperdynamic circulation and nitric oxide in renal impairment.
• To discuss recent advances in diagnostic criteria and therapeutic strategies for hepatorenal syndrome.

Main Methods:

• Review of clinical observations and recent scientific studies on circulatory changes in cirrhosis.
• In vivo and in vitro investigations into the role of nitric oxide in vasodilatation.
• Analysis of the impact of renal dysfunction on patient prognosis and mortality.

Main Results:

• Peripheral arterial vasodilatation and subsequent hyperdynamic circulation are strongly suggested to cause renal dysfunction in cirrhosis.
• Splanchnic arterial vasodilatation appears to precede increased splanchnic blood flow.
• Renal dysfunction, including hyponatremia, ascites, and azotemia, is linked to higher complication rates and mortality.

Conclusions:

• Understanding the pathophysiology of renal dysfunction has led to improved diagnostic and therapeutic approaches.
• Hepatorenal syndrome is potentially reversible with treatments like systemic vasoconstrictors and albumin.
• These therapies offer promising bridging options for liver transplant candidates.